Immunovant (IMVT) Return on Capital Employed (QoQ) (2020 - 2026)
Immunovant (IMVT) Return on Capital Employed (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Immunovant | 7.17 Bn | 7.17 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,920.00 |
| Dec 31, 2025 | -1,058.00 |
| Sep 30, 2025 | -2,897.00 |
| Jun 30, 2025 | -4,321.00 |
| Mar 31, 2025 | 1,942.00 |
| Dec 31, 2024 | -5,263.00 |
| Sep 30, 2024 | -1,625.00 |
| Jun 30, 2024 | 2,263.00 |
| Mar 31, 2024 | -4,253.00 |
| Dec 31, 2023 | 1,438.00 |
| Sep 30, 2023 | 13,483.00 |
| Jun 30, 2023 | 2,627.00 |
| Mar 31, 2023 | -363.00 |
| Dec 31, 2022 | 2,170.00 |
| Sep 30, 2022 | -700.00 |
| Jun 30, 2022 | -500.00 |
| Mar 31, 2022 | -555.00 |
| Dec 31, 2021 | 195.00 |
| Sep 30, 2021 | -3,134.00 |
| Jun 30, 2021 | -1,485.00 |